Evidence map›Paper›PMID 36942230›Full record

ReviewHeliyon2023

The use of animal by-products in a circular bioeconomy: Time for a TSE road map 3?

Nathan Meijer, Leo W D Van Raamsdonk, Elise W J Gerrits, Marko J Appel

Full text readReview
In one paragraph

Review in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nathan MeijerWageningen Food Safety Research (WFSR), Akkermaalsbos 2, 6708 WB Wageningen, the Netherlands.
Leo W D Van RaamsdonkWageningen Food Safety Research (WFSR), Akkermaalsbos 2, 6708 WB Wageningen, the Netherlands.
Elise W J GerritsWageningen Food Safety Research (WFSR), Akkermaalsbos 2, 6708 WB Wageningen, the Netherlands.
Marko J AppelWageningen Food Safety Research (WFSR), Akkermaalsbos 2, 6708 WB Wageningen, the Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In 2005 and 2010, the European Commission (EC) published two subsequent 'Road Maps' to provide options for relaxation of the bans on the application of animal proteins in feed. Since then, the food production system has changed considerably and demands for more sustainability and circularity are growing louder. Many relaxations envisioned in the second Road Map have by now been implemented, such as the use of processed animal proteins (PAPs) from poultry in pig feed and vice versa. However, some legislative changes, in particular concerning insects, had not been foreseen. In this article, we present a new vision on legislation for increased and improved use of animal by-products. Six current legislative principles are discussed for the bans on animal by-products as feed ingredients: feed bans; categorization of farmed animals; prohibition unless explicitly approved; approved processing techniques, the categorization of animal by-products, and monitoring methods. We provide a proposal for new guiding principles and future directions, and several concrete options for further relaxations. We argue that biological nature of farmed animals in terms of dietary preferences should be better recognised, that legal zero-tolerance limits should be expanded if safe, and that legislation should be revised and simplified.

Indexed as

Animal proteinsBSE, Bovine Spongiform EncephalopathyCJD, Creutzfeldt-Jakob diseaseEFSA, European Food Safety AuthorityEU, European UnionEURL, European Reference Laboratory for Animal ProteinsLegislationPAP, Processed Animal ProteinPCR, Polymerase Chain ReactionQRA, Quantitative Risk AssessmentSustainabilityTSETSE, Transmissible Spongiform EncephalopathyWOAH, World Organization for Animal Health

Identifiers

PMID36942230
PMCPMC10023914

What OpenQuestion holds

Textfull text, public
LicenceCC BY
reference markers read4
measurements read15
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.